vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer
Stock Information for vTv Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.